EDIT vs VZ · rev $32.3M vs P/E 11, rev $138.19B
Editas Medicine Inc (EDIT) versus Verizon Communications Inc (VZ) — a side-by-side from cached financials, not a winner call.
Editas Medicine Inc (EDIT) is a biotechnology company listed on NASDAQ.
Verizon Communications Inc (VZ) is a telecom services company listed on NYSE. It is led by Hans Vestberg.
Latest reported EDIT revenue for 2024-12-31 was $32.3M. Net income was -$237.1M. Revenue was down 58.6% from 2023-12-31 to 2024-12-31. EDIT currently screens at market cap $375.2M.
Latest reported VZ revenue for 2025-12-31 was $138.19B. Net income was $17.17B. Revenue was up 2.5% from 2024-12-31 to 2025-12-31. VZ currently screens at market cap $191.41B and trailing P/E 11.2.
EDIT currently screens at market cap $375.2M. VZ currently screens at market cap $191.41B and trailing P/E 11.2.
Not investment advice. Open the EDIT and VZ stock pages for the full models.
Not investment advice.